Free Trial

Elanco Animal Health (ELAN) Competitors

Elanco Animal Health logo
$13.82 -0.35 (-2.47%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$13.77 -0.05 (-0.33%)
As of 06/13/2025 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELAN vs. BNTX, TEVA, SMMT, GMAB, ITCI, RDY, MRNA, ASND, VTRS, and QGEN

Should you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Intra-Cellular Therapies (ITCI), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Ascendis Pharma A/S (ASND), Viatris (VTRS), and Qiagen (QGEN). These companies are all part of the "pharmaceutical products" industry.

Elanco Animal Health vs. Its Competitors

BioNTech (NASDAQ:BNTX) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Elanco Animal Health has a net margin of 4.60% compared to BioNTech's net margin of -15.16%. Elanco Animal Health's return on equity of 6.78% beat BioNTech's return on equity.

Company Net Margins Return on Equity Return on Assets
BioNTech-15.16% -2.35% -2.05%
Elanco Animal Health 4.60%6.78%3.03%

BioNTech has higher earnings, but lower revenue than Elanco Animal Health. BioNTech is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioNTech$2.75B9.33$1.01B-$3.40-31.34
Elanco Animal Health$4.43B1.55-$1.23B$0.7418.68

BioNTech has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500.

BioNTech currently has a consensus target price of $138.25, indicating a potential upside of 29.72%. Elanco Animal Health has a consensus target price of $15.17, indicating a potential upside of 9.74%. Given BioNTech's stronger consensus rating and higher possible upside, analysts clearly believe BioNTech is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioNTech
0 Sell rating(s)
4 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.83
Elanco Animal Health
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

15.5% of BioNTech shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 19.2% of BioNTech shares are held by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, BioNTech had 19 more articles in the media than Elanco Animal Health. MarketBeat recorded 24 mentions for BioNTech and 5 mentions for Elanco Animal Health. BioNTech's average media sentiment score of 0.54 beat Elanco Animal Health's score of 0.36 indicating that BioNTech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioNTech
7 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Positive
Elanco Animal Health
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BioNTech received 7 more outperform votes than Elanco Animal Health when rated by MarketBeat users. However, 54.96% of users gave Elanco Animal Health an outperform vote while only 47.04% of users gave BioNTech an outperform vote.

CompanyUnderperformOutperform
BioNTechOutperform Votes
151
47.04%
Underperform Votes
170
52.96%
Elanco Animal HealthOutperform Votes
144
54.96%
Underperform Votes
118
45.04%

Summary

BioNTech beats Elanco Animal Health on 10 of the 19 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELAN vs. The Competition

MetricElanco Animal HealthPharmaceutical IndustryMedical SectorNYSE Exchange
Market Cap$6.86B$6.88B$5.57B$19.68B
Dividend YieldN/A2.48%5.27%3.80%
P/E Ratio34.558.4626.7534.98
Price / Sales1.55261.91403.9842.66
Price / Cash4.8465.8538.2517.51
Price / Book1.096.526.964.78
Net Income-$1.23B$143.26M$3.23B$1.02B
7 Day Performance-0.90%-0.21%-1.22%0.82%
1 Month Performance6.72%10.62%6.34%1.32%
1 Year Performance-23.35%3.63%33.05%10.65%

Elanco Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELAN
Elanco Animal Health
1.0265 of 5 stars
$13.82
-2.5%
$15.17
+9.7%
-23.4%$6.86B$4.43B34.559,800Gap Down
BNTX
BioNTech
2.8434 of 5 stars
$108.97
+0.4%
$138.25
+26.9%
+15.7%$26.20B$2.75B-51.893,080Trending News
TEVA
Teva Pharmaceutical Industries
3.9967 of 5 stars
$18.07
+1.7%
$24.44
+35.3%
-0.9%$20.73B$16.62B-12.4636,800Gap Down
SMMT
Summit Therapeutics
3.0602 of 5 stars
$21.56
+4.7%
$37.40
+73.5%
+135.8%$16.01B$700K-77.00110News Coverage
Analyst Upgrade
Analyst Revision
Gap Down
GMAB
Genmab A/S
3.8235 of 5 stars
$22.25
+0.2%
$39.17
+76.0%
-12.9%$14.27B$3.12B12.791,660Analyst Downgrade
ITCI
Intra-Cellular Therapies
0.8657 of 5 stars
$131.87
flat
$109.70
-16.8%
N/A$14.05B$680.50M-151.57560
RDY
Dr. Reddy's Laboratories
1.3642 of 5 stars
$15.64
+0.5%
$16.95
+8.4%
+9.9%$13.05B$325.54B24.9024,800
MRNA
Moderna
4.4486 of 5 stars
$28.14
+2.5%
$53.58
+90.4%
-81.0%$10.88B$3.14B-3.033,900Trending News
Options Volume
Gap Down
ASND
Ascendis Pharma A/S
3.3753 of 5 stars
$173.15
+0.1%
$217.73
+25.7%
+33.8%$10.56B$368.70M-24.39640Analyst Forecast
Analyst Revision
VTRS
Viatris
2.5367 of 5 stars
$8.81
+1.1%
$10.40
+18.0%
-12.3%$10.34B$14.33B-11.9137,000
QGEN
Qiagen
3.3159 of 5 stars
$46.17
+1.5%
$48.42
+4.9%
+14.4%$10.26B$2.00B128.566,030

Related Companies and Tools


This page (NYSE:ELAN) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners